CLINICAL_TRIALS
trial_result
· 2019-02-04
Clinical Trial Update: Spinal Cord Stimulation For Heart Failure [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 trial of spinal cord stimulation for systolic heart failure conducted by Abbott Medical Devices has completed. No results are provided in the …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Systolic Heart Failure | Phase 2, Phase 3 | Status: COMPLETED